Back to results
US 2013/0158080 A1Published application
Methods for treating hypertension in black patients
AssigneeTakeda Pharmaceuticals U.S.A., Inc.
InventorStuart Kupfer
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating hypertension in a black patient using a therapeutically effective amount of a combination of an angiotensin II receptor blocker and chlorthalidone.
Claims38
A method of lowering blood pressure in a black patient in need of treatment thereof, the method comprising the steps of:
- preferentially selecting a therapeutically effective amount of at least one angiotensin II receptor blocker (ARB) from a class of ARBs to lower the blood pressure in a black patient, wherein the ARB selected is azilsartan medoxomil;
- and
- administering a combination of a therapeutically effective amount of the azilsartan medoxomil and a therapeutically effective amount of chlorthalidone to lower the blood pressure of the black patient.
A method of lowering blood pressure in a black patient in need of treatment thereof, the method comprising the steps of:
- preferentially administering a combination of a therapeutically effective amount of at least one angiotensin II receptor blocker (ARB) from a class of ARBs and a therapeutically effective amount of chlorthalidone to lower the blood pressure in a black patient, wherein the ARB administered to the black patient is azilsartan medoxomil.
Dependencies are inferred from the claim text.